Creative Medical Technology Holdings, Inc. Warrant Exercise Inducement

On October 29, 2025, Creative Medical Technology Holdings, Inc. entered into warrant exercise inducement offer letters with holders of warrants to purchase an aggregate of 1,116,136 shares of the Company’s common stock. The holders agreed to exercise the existing warrants at their current exercise price of $3.75 per share, in exchange for the Company’s agreement to issue new warrants to purchase an aggregate of 2,790,340 shares of common stock. The aggregate gross proceeds from the exercise of the existing warrants will be approximately $4.2 million, before deducting financial advisory fees. The net proceeds will be used for working capital and general corporate purposes. The new warrants have an exercise price of $3.75 per share, subject to reduction based on the lowest VWAP of the Company’s common stock during a five-day trading period. The warrants will not be exercisable until stockholder approval is obtained, and then will be exercisable for five years. The Company also agreed to reduce the exercise price of certain warrants issued in May 2022 and December 2021 to $4.73 per share and to issue additional warrants to an investor. Roth Capital Partners, LLC acted as the Company’s financial advisor in connection with the transactions.